[2-[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]-3,3-dimethylbutyl]-[1-(4-chlorophenyl)cyclopropyl]carbamic acid
C45H66ClNO4 — CID 118276524
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]-3,3-dimethylbutyl]-[1-(4-chlorophenyl)cyclopropyl]carbamic acid
[2-[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]-3,3-dimethylbutyl]-[1-(4-chlorophenyl)cyclopropyl]carbamic acid (PubChem CID 118276524) has the molecular formula C45H66ClNO4 and a molecular weight of 720.48 g/mol. Its IUPAC name is [2-[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]-3,3-dimethylbutyl]-[1-(4-chlorophenyl)cyclopropyl]carbamic acid.
Molecular Properties
| Compound Name | [2-[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]-3,3-dimethylbutyl]-[1-(4-chlorophenyl)cyclopropyl]carbamic acid |
|---|---|
| PubChem CID | 118276524 |
| Molecular Formula | C45H66ClNO4 |
| Molecular Weight | 720.48 g/mol |
| Exact Mass | 719.47 |
| IUPAC Name | [2-[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]-3,3-dimethylbutyl]-[1-(4-chlorophenyl)cyclopropyl]carbamic acid |
| SMILES | CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(C(CN(C(=O)O)C2(c3ccc(Cl)cc3)CC2)C(C)(C)C)CC1=O |
| InChI | InChI=1S/C45H66ClNO4/c1-27(2)36-31(48)25-44(34(39(3,4)5)26-47(38(50)51)45(23-24-45)28-11-13-29(46)14-12-28)22-21-42(9)30(37(36)44)15-16-33-41(8)19-18-35(49)40(6,7)32(41)17-20-43(33,42)10/h11-14,27,30,32-35,49H,15-26H2,1-10H3,(H,50,51)/t30-,32+,33-,34?,35+,41+,42-,43-,44-/m1/s1 |
| InChIKey | XVCIVAMDTXFSAP-ATGRCCTMSA-N |
| XLogP | 11.31 |
| TPSA | 77.84 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 720.48 |
| LogP ≤ 5 | 11.31 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118276524 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.